HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 495 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,758 | -82.3% | 25,267 | -81.6% | 0.01% | -84.7% |
| Q4 2022 | $15,610 | -99.8% | 137,167 | -14.4% | 0.06% | +40.5% |
| Q3 2022 | $9,922,000 | -45.1% | 160,315 | -29.3% | 0.04% | -47.5% |
| Q2 2022 | $18,086,000 | -24.9% | 226,760 | -1.0% | 0.08% | -13.0% |
| Q1 2022 | $24,096,000 | +26.8% | 229,028 | +29.9% | 0.09% | +26.0% |
| Q4 2021 | $19,004,000 | +2.3% | 176,353 | +4.0% | 0.07% | -3.9% |
| Q3 2021 | $18,574,000 | +45.3% | 169,565 | +24.2% | 0.08% | +26.7% |
| Q2 2021 | $12,782,000 | +78.2% | 136,502 | +75.2% | 0.06% | +62.2% |
| Q1 2021 | $7,172,000 | +47.1% | 77,925 | +17.0% | 0.04% | +32.1% |
| Q4 2020 | $4,874,000 | -3.1% | 66,626 | +2.9% | 0.03% | -12.5% |
| Q3 2020 | $5,032,000 | +38.7% | 64,773 | -0.7% | 0.03% | +33.3% |
| Q2 2020 | $3,627,000 | – | 65,261 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 548,715 | $59,130,000 | 25.86% |
| Paulson & Co. | 6,000,000 | $646,560,000 | 19.94% |
| Avoro Capital Advisors LLC | 9,295,000 | $1,001,629,000 | 17.05% |
| Asymmetry Capital Management, L.P. | 137,610 | $14,829,000 | 7.87% |
| 1492 Capital Management LLC | 119,995 | $12,931,000 | 6.37% |
| Eversept Partners, LP | 833,750 | $89,844,900 | 5.74% |
| HealthCor Management, L.P. | 832,270 | $89,685,000 | 4.88% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 1,063,236 | $114,574,000 | 4.38% |
| PFM Health Sciences, LP | 1,091,840 | $117,657,000 | 4.01% |
| Ikarian Capital, LLC | 246,900 | $26,607,000 | 3.96% |